Elucidating the specific mechanisms by which HMGB1 signaling triggers subacute and long-term neuroinflammation that may lead to post-stroke cognitive deficits is an important avenue for the development of targeted therapies to improve functional outcomes after ischemic brain injury. Here, HMGB1 is linked to stroke disorder.